Mosquito Passage Dramatically Changes var Gene Expression in Controlled Human Plasmodium falciparum Infections

Virulence of the most deadly malaria parasite Plasmodium falciparum is linked to the variant surface antigen PfEMP1, which is encoded by about 60 var genes per parasite genome. Although the expression of particular variants has been associated with different clinical outcomes, little is known about...

Full description

Saved in:
Bibliographic Details
Published inPLoS pathogens Vol. 12; no. 4; p. e1005538
Main Authors Bachmann, Anna, Petter, Michaela, Krumkamp, Ralf, Esen, Meral, Held, Jana, Scholz, Judith A M, Li, Tao, Sim, B Kim Lee, Hoffman, Stephen L, Kremsner, Peter G, Mordmüller, Benjamin, Duffy, Michael F, Tannich, Egbert
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 01.04.2016
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Virulence of the most deadly malaria parasite Plasmodium falciparum is linked to the variant surface antigen PfEMP1, which is encoded by about 60 var genes per parasite genome. Although the expression of particular variants has been associated with different clinical outcomes, little is known about var gene expression at the onset of infection. By analyzing controlled human malaria infections via quantitative real-time PCR, we show that parasite populations from 18 volunteers expressed virtually identical transcript patterns that were dominated by the subtelomeric var gene group B and, to a lesser extent, group A. Furthermore, major changes in composition and frequency of var gene transcripts were detected between the parental parasite culture that was used to infect mosquitoes and Plasmodia recovered from infected volunteers, suggesting that P. falciparum resets its var gene expression during mosquito passage and starts with the broad expression of a specific subset of var genes when entering the human blood phase.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
TL (Senior Director), BKLS (Executive Vice President Process Development and Manufacturing) and SLH (Chief Executive and Scientific Officer) are employees of Sanaria Inc. This affiliation does not alter our adherence to all PLOS policies on sharing data and materials. All other authors declare that no competing interests exists.
Conceived and designed the experiments: AB MP MFD ET. Performed the experiments: AB MP JAMS. Analyzed the data: AB MP RK MFD. Contributed reagents/materials/analysis tools: TL BKLS SLH. Wrote the paper: AB MP MFD ET. Designed the CHMI trial: BM PGK SLH. Collected the blood samples: JH ME.
ISSN:1553-7374
1553-7366
1553-7374
DOI:10.1371/journal.ppat.1005538